BuzzSparks.org

Johnson & Johnson Development


Organized in 1973, Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC makes private equity investments in venture funded health care companies. Portfolio companies include those in...

Founded in 1973
Homepage:

HQ

08901 410 George Street

New Brunswick
USA NJ

January, 2012

Johnson & Johnson Development invested $12.5M in PowerVision as a Series C round

July, 2011

Johnson & Johnson Development invested $26.8M in Atlas Genetics as a Series B round

June, 2011

Johnson & Johnson Development invested $30M in Spinal Modulation as a Series D round

January, 2011

Johnson & Johnson Development invested $9M in 23andMe as a Series C round

Johnson & Johnson Development invested $12.3M in Zeo as a Series C round

Johnson & Johnson Development invested $35M in Genocea Biosciences as a Series B round

November, 2010

Johnson & Johnson Development invested $29M in Syntaxin as a Series C round

October, 2010

Johnson & Johnson Development invested $8.1M in Intio as a Series B round

June, 2010

Johnson & Johnson Development invested $25M in Aquinox Pharmaceuticals as a Series B round

January, 2010

Johnson & Johnson Development invested $25M in PhaseBio Pharmaceuticals as a Series B round

December, 2009

Johnson & Johnson Development invested $44.2M in Molecular Partners as a Series B round

November, 2009

Johnson & Johnson Development invested $27.4M in Spinal Modulation as a Series C round

Johnson & Johnson Development invested $21.8M in Celladon as a Series C round

October, 2009

Johnson & Johnson Development invested $20M in Sleep Solutions as a Series F round

Johnson & Johnson Development invested $40M in Direct Flow Medical as a Series C round

May, 2009

Johnson & Johnson Development invested $20.5M in iScience Interventional as a Series F round

August, 2008

Johnson & Johnson Development invested $27.5M in Brainsgate as unattributed round

Johnson & Johnson Development invested $9M in Neuron Systems as a Series A round

February, 2008

Johnson & Johnson Development invested $11M in InSound Medical as a Series E round

October, 2007

Johnson & Johnson Development invested $32M in Syntaxin as a Series B round

Johnson & Johnson Development invested $6.6M in PhaseBio Pharmaceuticals as a Series B round

Johnson & Johnson Development invested $33M in Tengion as a Series C round

May, 2007

Johnson & Johnson Development invested $30M in Biolex Therapeutics as a Series C round

March, 2007

Johnson & Johnson Development invested $15.3M in Axial Biotech as a Series B round

June, 2006

Johnson & Johnson Development invested $50M in Tengion as a Series B round

December, 2005

Johnson & Johnson Development invested $67M in Light Sciences Oncology as a Series A round

1973

Johnson & Johnson Development was founded in 1973